Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...
Blog Post
December 02, 2021
Many countries around the world have punished most of the African continent for the scientific discovery of the Omicron variant through the imposition of travel bans. These travel bans are more injury upon the injury of low vaccination in Africa. Even well-intentioned rallying phrases such as “vacci...
Blog Post
December 01, 2021
We worked with the Joint Learning Network (JLN) Efficiency Collaborative to gain insights from Collaborative members who represent technical staff and decision-makers working at the heart of health benefit packages development and revisions in eleven low-and middle-income countries in Africa and Asi...
Blog Post
November 10, 2021
Tobacco use is the world’s leading cause of preventable death, claiming eight million lives per year, which together with tobacco-attributable disability is equivalent to an annual global productivity loss of 1.8 percent of GDP. Extensive evidence shows that tobacco taxation is the most effective an...
Blog Post
November 04, 2021
In this blog, we provide a rapid overview of the sources and wider uses of medicines data to strengthen health systems in LMIC settings, with a focus on Ghana. We argue that having credible and comprehensive data on medicines use leads to better decision making and better medicines policy. These are...